Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Small Cell Lung Carcinoma 1Neoplasms, Germ Cell and Embryonal 1

Interventions

Etoposide 4Cisplatin 4lutetium Lu 177 dotatate 2fludarabine phosphate 2fludarabine 2Cyclophosphamide 2Bleomycin 2repotrectinib 1pegfilgrastim 1etoposide phosphate 1copper dotatate CU-64 1Watchful Waiting 1Vorinostat 1Teniposide 1Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Respiratory Physiological Phenomena 1Practice Guidelines as Topic 1Platinum 1Nivolumab 1Mesna 1Magnetic Resonance Spectroscopy 1Lutetium-177 1Lutetium 1Injections 1Immunotherapy 1Filgrastim 1Drug Therapy 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Neoplasms, Germ Cell and Embryonal × Teniposide × Clear all
NCT07188441 2025-09-23

Treatment of Newly Diagnosed Central Malignant Germ Cell Tumor People With Teniposide Injection Combined With Cisplatin.

Sun Yat-sen University

Phase 2 Recruiting
40 enrolled

Neoplasms, Germ Cell and Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡